_id
690f3648ccc777a4e85d174f
Ticker
BLFS
Name
BioLife Solutions Inc
Exchange
NASDAQ
Address
3303 Monte Villa Parkway, Bothell, WA, United States, 98021
Country
USA
Sector
Healthcare
Industry
Medical Instruments & Supplies
Currency
USD
Website
https://www.biolifesolutions.com
Description
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
Last Close
24.88
Volume
382602
Current Price
24.39
Change
-1.9694533762057815
Last Updated
2025-11-28T12:58:09.158Z
Image
data:image/webp;base64,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
Ipo Date
1989-11-22T00:00:00.000Z
Market Cap
1284589952
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9193545454545454
Sentiment Sources
11
Rating
4.7778
Target Price
32.1
Strong Buy
7
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
28067000
Cost Of Revenue
9288000
Gross Profit
18779000
Operating Expenses
18158000
Operating Income
621000
Interest Expense
508000
Pretax Income
703000
Net Income
621000
Eps
0.012745380646129227
Dividends Per Share
-
Shares Outstanding
48148046
Income Tax Expense
82000
EBITDA
2546000
Operating Margin
2.2125627961663166
Total Other Income Expense Net
82000
Cash
29481000
Short Term Investments
49473000
Receivables
10842000
Inventories
27825000
Total Current Assets
126566000
Property Plant Equipment
18734000
Total Assets
392081000
Payables
2890000
Short Term Debt
9670000
Long Term Debt
-
Total Liabilities
38342000
Equity
353739000
Depreciation
1335000
Change In Working Capital
3677000
Cash From Operations
6104000
Capital Expenditures
3302000
Cash From Investing
-5967000
Cash From Financing
5870000
Net Change In Cash
-2421000
PE
-
PB
3.3594458588111578
ROE
0.17555316207712465
ROA
0.15838563970200034
FCF
2802000
Fcf Percent
0.09983254355648982
Piotroski FScore
4
Health Score
55
Deep Value Investing Score
7.5
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
6.3
Garp Investing Score
5
Growth Investing Score
3.5
Momentum Investing Score
5.5
Net Net Investing Score
4
Quality Investing Score
5
Value Investing Score
6.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
28067000
Quarters > 0 > income Statement > cost Of Revenue
9288000
Quarters > 0 > income Statement > gross Profit
18779000
Quarters > 0 > income Statement > operating Expenses
18158000
Quarters > 0 > income Statement > operating Income
621000
Quarters > 0 > income Statement > interest Expense
508000
Quarters > 0 > income Statement > pretax Income
703000
Quarters > 0 > income Statement > net Income
621000
Quarters > 0 > income Statement > eps
0.012745380646129227
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
48723535
Quarters > 0 > income Statement > income Tax Expense
82000
Quarters > 0 > income Statement > EBITDA
2546000
Quarters > 0 > income Statement > operating Margin
2.2125627961663166
Quarters > 0 > income Statement > total Other Income Expense Net
82000
Quarters > 0 > balance Sheet > cash
29481000
Quarters > 0 > balance Sheet > short Term Investments
49473000
Quarters > 0 > balance Sheet > receivables
10842000
Quarters > 0 > balance Sheet > inventories
27825000
Quarters > 0 > balance Sheet > total Current Assets
126566000
Quarters > 0 > balance Sheet > property Plant Equipment
18734000
Quarters > 0 > balance Sheet > total Assets
392081000
Quarters > 0 > balance Sheet > payables
2890000
Quarters > 0 > balance Sheet > short Term Debt
9670000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
38342000
Quarters > 0 > balance Sheet > equity
353739000
Quarters > 0 > cash Flow > net Income
621000
Quarters > 0 > cash Flow > depreciation
1335000
Quarters > 0 > cash Flow > change In Working Capital
3677000
Quarters > 0 > cash Flow > cash From Operations
6104000
Quarters > 0 > cash Flow > capital Expenditures
3302000
Quarters > 0 > cash Flow > cash From Investing
-5967000
Quarters > 0 > cash Flow > cash From Financing
5870000
Quarters > 0 > cash Flow > net Change In Cash
-2421000
Quarters > 0 > ratios > PE
0.012745380646129227
Quarters > 0 > ratios > PB
3.3594458588111578
Quarters > 0 > ratios > ROE
0.17555316207712465
Quarters > 0 > ratios > ROA
0.15838563970200034
Quarters > 0 > ratios > FCF
2802000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.09983254355648982
Quarters > 0 > health Score
55
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
25421000
Quarters > 1 > income Statement > cost Of Revenue
8988000
Quarters > 1 > income Statement > gross Profit
16433000
Quarters > 1 > income Statement > operating Expenses
33076000
Quarters > 1 > income Statement > operating Income
-16643000
Quarters > 1 > income Statement > interest Expense
684000
Quarters > 1 > income Statement > pretax Income
-15712000
Quarters > 1 > income Statement > net Income
-15838000
Quarters > 1 > income Statement > eps
-0.3313517641458311
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
47798146
Quarters > 1 > income Statement > income Tax Expense
126000
Quarters > 1 > income Statement > EBITDA
-14330000
Quarters > 1 > income Statement > operating Margin
-65.46949372565989
Quarters > 1 > income Statement > total Other Income Expense Net
931000
Quarters > 1 > balance Sheet > cash
31902000
Quarters > 1 > balance Sheet > short Term Investments
49864000
Quarters > 1 > balance Sheet > receivables
10060000
Quarters > 1 > balance Sheet > inventories
27690000
Quarters > 1 > balance Sheet > total Current Assets
125432000
Quarters > 1 > balance Sheet > property Plant Equipment
17199000
Quarters > 1 > balance Sheet > total Assets
387240000
Quarters > 1 > balance Sheet > payables
3209000
Quarters > 1 > balance Sheet > short Term Debt
12217000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
40085000
Quarters > 1 > balance Sheet > equity
347155000
Quarters > 1 > cash Flow > net Income
-15838000
Quarters > 1 > cash Flow > depreciation
1382000
Quarters > 1 > cash Flow > change In Working Capital
85000
Quarters > 1 > cash Flow > cash From Operations
7368000
Quarters > 1 > cash Flow > capital Expenditures
1743000
Quarters > 1 > cash Flow > cash From Investing
-39533000
Quarters > 1 > cash Flow > cash From Financing
-2878000
Quarters > 1 > cash Flow > net Change In Cash
-35042999
Quarters > 1 > ratios > PE
-0.3313517641458311
Quarters > 1 > ratios > PB
3.3581448659532485
Quarters > 1 > ratios > ROE
-4.5622272471950565
Quarters > 1 > ratios > ROA
-4.089970044416899
Quarters > 1 > ratios > FCF
5625000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.22127375004917194
Quarters > 1 > health Score
49
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
23941000
Quarters > 2 > income Statement > cost Of Revenue
8155000
Quarters > 2 > income Statement > gross Profit
15786000
Quarters > 2 > income Statement > operating Expenses
17004000
Quarters > 2 > income Statement > operating Income
-1218000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-434000
Quarters > 2 > income Statement > net Income
-448000
Quarters > 2 > income Statement > eps
-0.009504670866825982
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
47134720
Quarters > 2 > income Statement > income Tax Expense
14000
Quarters > 2 > income Statement > EBITDA
166000
Quarters > 2 > income Statement > operating Margin
-5.0875067875193185
Quarters > 2 > income Statement > total Other Income Expense Net
784000
Quarters > 2 > balance Sheet > cash
66945000
Quarters > 2 > balance Sheet > short Term Investments
21635000
Quarters > 2 > balance Sheet > receivables
9167000
Quarters > 2 > balance Sheet > inventories
27566000
Quarters > 2 > balance Sheet > total Current Assets
131129000
Quarters > 2 > balance Sheet > property Plant Equipment
16733000
Quarters > 2 > balance Sheet > total Assets
395141000
Quarters > 2 > balance Sheet > payables
3297000
Quarters > 2 > balance Sheet > short Term Debt
12284000
Quarters > 2 > balance Sheet > long Term Debt
2499000
Quarters > 2 > balance Sheet > total Liabilities
42517000
Quarters > 2 > balance Sheet > equity
352624000
Quarters > 2 > cash Flow > net Income
-448000
Quarters > 2 > cash Flow > depreciation
1384000
Quarters > 2 > cash Flow > change In Working Capital
-3762000
Quarters > 2 > cash Flow > cash From Operations
1727000
Quarters > 2 > cash Flow > capital Expenditures
175000
Quarters > 2 > cash Flow > cash From Investing
-27176000
Quarters > 2 > cash Flow > cash From Financing
-2992000
Quarters > 2 > cash Flow > net Change In Cash
-28441000
Quarters > 2 > ratios > PE
-0.009504670866825982
Quarters > 2 > ratios > PB
3.260174635872771
Quarters > 2 > ratios > ROE
-0.12704750669268117
Quarters > 2 > ratios > ROA
-0.11337725014615035
Quarters > 2 > ratios > FCF
1552000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.06482603065870264
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
-3424000
Quarters > 3 > income Statement > cost Of Revenue
11695000
Quarters > 3 > income Statement > gross Profit
8271000
Quarters > 3 > income Statement > operating Expenses
-16505000
Quarters > 3 > income Statement > operating Income
1386000
Quarters > 3 > income Statement > interest Expense
116000
Quarters > 3 > income Statement > pretax Income
1543000
Quarters > 3 > income Statement > net Income
12459000
Quarters > 3 > income Statement > eps
0.25938579342822704
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
48032700
Quarters > 3 > income Statement > income Tax Expense
-131000
Quarters > 3 > income Statement > EBITDA
6747000
Quarters > 3 > income Statement > operating Margin
-40.478971962616825
Quarters > 3 > income Statement > total Other Income Expense Net
157000
Quarters > 3 > balance Sheet > cash
95386000
Quarters > 3 > balance Sheet > short Term Investments
9198000
Quarters > 3 > balance Sheet > receivables
9168000
Quarters > 3 > balance Sheet > inventories
29013000
Quarters > 3 > balance Sheet > total Current Assets
148761000
Quarters > 3 > balance Sheet > property Plant Equipment
16758000
Quarters > 3 > balance Sheet > total Assets
399487000
Quarters > 3 > balance Sheet > payables
3573000
Quarters > 3 > balance Sheet > short Term Debt
12454000
Quarters > 3 > balance Sheet > long Term Debt
4997000
Quarters > 3 > balance Sheet > total Liabilities
50578000
Quarters > 3 > balance Sheet > equity
348909000
Quarters > 3 > cash Flow > net Income
12459000
Quarters > 3 > cash Flow > depreciation
1704000
Quarters > 3 > cash Flow > change In Working Capital
1123000
Quarters > 3 > cash Flow > cash From Operations
1645000
Quarters > 3 > cash Flow > capital Expenditures
1062000
Quarters > 3 > cash Flow > cash From Investing
73637000
Quarters > 3 > cash Flow > cash From Financing
-4086000
Quarters > 3 > cash Flow > net Change In Cash
71225000
Quarters > 3 > ratios > PE
0.25938579342822704
Quarters > 3 > ratios > PB
3.357659312313526
Quarters > 3 > ratios > ROE
3.570845120074289
Quarters > 3 > ratios > ROA
3.118749796614158
Quarters > 3 > ratios > FCF
583000
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
-0.17026869158878505
Quarters > 3 > health Score
51
Valuation > metrics > PE
0.012745380646129227
Valuation > metrics > PB
3.3594458588111578
Valuation > final Score
66.40554141188842
Valuation > verdict
43.9% Undervalued
Profitability > metrics > ROE
0.17555316207712465
Profitability > metrics > ROA
0.49065309798840134
Profitability > metrics > Net Margin
0.022125627961663164
Profitability > final Score
5
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.10839064960323855
Risk > metrics > Interest Coverage
1.2224409448818898
Risk > final Score
65
Risk > verdict
High
Liquidity > metrics > Current Ratio
10.076910828025477
Liquidity > metrics > Quick Ratio
7.861544585987261
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
46.418551340467516
Prev Valuations > 1
47.39825364127229
Prev Valuations > 2
66.42340687686473
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
32
Prev Risks > 0
-37
Prev Risks > 1
52
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:17:09.925Z
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABioLife Solutions (NASDAQ:BLFS) Cut to “Hold” at Zacks Research Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$32.1
Analyst Picks
Strong Buy
7
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Medium
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 79.03% of the total shares of BioLife Solutions Inc
1.
Casdin Capital, LLC(16.1119%)
since
2025/06/30
2.
BlackRock Inc(11.5764%)
since
2025/06/30
3.
T. Rowe Price Investment Management,Inc.(8.8778%)
since
2025/06/30
4.
Amvescap Plc.(7.4857%)
since
2025/06/30
5.
Vanguard Group Inc(6.0568%)
since
2025/06/30
6.
State Street Corp(2.9454%)
since
2025/06/30
7.
Fred Alger Management, LLC(2.609%)
since
2025/06/30
8.
Massachusetts Financial Services Company(2.3039%)
since
2025/06/30
9.
Rockefeller Capital Management L.P.(2.3007%)
since
2025/06/30
10.
Ameriprise Financial Inc(2.2585%)
since
2025/06/30
11.
Dimensional Fund Advisors, Inc.(2.0554%)
since
2025/06/30
12.
Geode Capital Management, LLC(1.9256%)
since
2025/06/30
13.
Palisade Capital Management LLc(1.9221%)
since
2025/06/30
14.
Geneva Capital Management(1.8851%)
since
2025/06/30
15.
Royal Bank of Canada(1.6543%)
since
2025/06/30
16.
ING Investment Management LLC(1.5054%)
since
2025/06/30
17.
Cramer Rosenthal McGlynn LLC(1.472%)
since
2025/06/30
18.
Bank of America Corp(1.4043%)
since
2025/06/30
19.
Granahan Investment Management Inc..(1.3446%)
since
2025/06/30
20.
Mutual Of America Capital Management LLC(1.3345%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.